First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary

Journal of Chemotherapy

Volumn 20, Issue 5, 2008, Pages 655-656

  Tóth, Ákos ^a   Kispal G Y ^b   Ungvari E ^a   Violka, M ^a   Szeberin, Z ^c   Paszti J ^a   Molnar K ^d   Gacs, M ^a   Fuzi M ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b Hetényi Hospital   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Office of the Chief Medical Officer   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; OXACILLIN; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AORTA DISSECTION; AORTA SURGERY; AUTOPSY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTEROBACTER CLOACAE; FATALITY; FEVER; HEARING TEST; HUMAN; HUNGARY; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; POSTOPERATIVE INFECTION; STAPHYLOCOCCUS INFECTION;

EID: 57049176084     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.5.655     Document Type: Letter

References (18)

1. Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 1992; 30 (7): 1654-1660.
2. Pérez-Roth E, Claverie-Martín F, Villar J, Méndez-Álvarez S. Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. J Clin Microbiol 2001; 39 (11): 4037-4041.
3. EARSS Management Team. EARSS manual 2005. EARSS Management Team, Bilthoven, The Netherlands 2005; [Online.] http://www.rivm.ni/earss/ tools/
4. Walsh TR, Blomström A, Qwärnström A, Ho P, Wootton M, Howe RA, et al.. Evaluation of current methods for detection of Staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39 (7): 2439-2444.
5. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for the characterization of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) clones of Staphylococcus aureus. J Clin Microbiol 2000; 38 (3): 1008-1015.
6. Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41 (12): 5442-5448.
7. Oliveira DC, Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46 (7): 2155-2161.
8. EARSS Management Team. EARSS annual reports. EARSS Management Team, Bilthoven, The Netherlands 2001-2006; [Online.] http://www.rivm.nl/earss/ database/
9. Moore MR, Perdreau-Remington F, Chambers HF. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 2003; 47 (4): 1262-1266.
10. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40 (1): 135-136.
11. Tenover FC, McDonald LC, Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr Opin Infect Dis 2005; 18 (4): 300-305.
12. Yanagihara K, Okada M, Fukuda Y, Imamura Y, Kaneko Y, Ohno H, et al. Efficacy of quinupristin-dalfopristin against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of hematogenous pulmonary infection. Chemotherapy 2004; 50 (5): 260-264.
13. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis 2004; 10 (5): 855-857.
14. Luczak-Kadlubowska A, Krzyszton-Russjan J, Hryniewicz W. Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins. J Clin Microbiol 2006; 44 (11): 4018-4024.
15. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99 (11): 7687-7692.
16. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47 (10): 3040-3045.
17. Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004; 48 (12): 4926-4928.
18. Conceiçãao T, Aires-de-Sousa M, Füzi M, Tóth Á, Pászti J, Ungvári E, et al. Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clin Microbiol Infect 2007; 13 (10): 971-979.